Ishita Drugs and Industries Ltd
Fri 4/09/2026,15:23:0 | BSE : ISHITADR
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 73.80
Previous Close
₹ 70.88
Volume
1026
Mkt Cap ( ₹ Cr)
₹ 21.80
High
₹ 73.80
Low
₹ 72.90
52 Week High
₹ 90.85
52 Week Low
₹ 66.00
Book Value Per Share
₹ 39.46
Dividend Yield
₹ 0.00
Face Value
₹₹10.00
What's Your Call?
Collective community sentiment on Ishita Drugs and Industries Ltd
Your Vote -
Buy
50.00%
Hold
0.00%
Sell
50.00%
50.00%
2 users have voted
Option Chain
Analyzes market sentiment, predicts Ishita Drugs and Industries Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Ishita Drugs & Ind. - Weblink Intimation Letter To The Shareholders
-
Ishita Drugs & Ind. - Reg. 34 (1) Annual Report.
-
Ishita Drugs & Ind. - NOTICE OF 33RD ANNUAL GENERAL MEETING (AGM) ALONG WITH THE E-VOTING PERIOD
-
Ishita Drugs & Ind. - INTIMATION OF E- VOTING AS PER THE REGULATION 44 OF SEBI (LODR) REGULATION, 2015
-
Ishita Drugs & Ind. - INTIMATION ABOUT THE BOOK CLOSURE FOR 33RD ANNUAL GENERAL MEETING (AGM)
-
Ishita Drugs & Ind. Q1 net profit down 23.33% at Rs 0.23 cr
-
Ishita Drugs & Ind. - Announcement under Regulation 30 (LODR)-Change in Management
-
Ishita Drugs & Ind. - Outcome Of Board Meeting Held On 08H August, 2026
-
Ishita Drugs & Ind. - Board Meeting Outcome for Outcome Of Board Meeting Held On 08Th August, 2026
-
Ishita Drugs & Ind. - Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of The SEBI (LODR) R
-
Ishita Drugs & Ind. has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026
-
Ishita Drugs & Ind. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Ishita Drugs & Ind. - Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations
-
Ishita Drugs & Ind. - Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations
Key fundamentals
Evaluate the intrinsic value of Ishita Drugs and Industries Ltd stockÂ
| Name | March-26 | March-25 | March-24 | March-23 | March-22 |
|---|---|---|---|---|---|
| Assets | 11.6499 | 14.6926 | 9.9215 | 10.1334 | 8.5956 |
| Liabilities | 11.6499 | 14.6926 | 9.9215 | 10.1334 | 8.5956 |
| Equity | 2.9903 | 2.9903 | 2.9903 | 2.9903 | 2.9903 |
| Gross Profit | 0.7656 | 1.0014 | 0.9084 | 0.7617 | 1.0911 |
| Net Profit | 0.7785 | 0.868 | 0.7485 | 0.5773 | 0.8049 |
| Cash From Operating Activities | 3.9193 | -3.6371 | 2.1207 | -2.8974 | 3.0763 |
| NPM(%) | 5.31 | 5.78 | 4.92 | 4.78 | 5.71 |
| Revenue | 14.6602 | 14.9972 | 15.1875 | 12.0723 | 14.0904 |
| Expenses | 13.8946 | 13.9957 | 14.2791 | 11.3106 | 12.9993 |
| ROE(%) | 6.59 | 7.35 | 6.34 | 4.89 | 6.82 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Ishita Drugs and Industries Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 863.00 | -0.52 | 21.76 | 40.45 | -26.19 | 0.58 |
| Lotus Eye Hospital and Institute Ltd | 109.90 | -0.68 | 1563.29 | 147.40 | 0.39 | 0.00 |
| Bharat Immunological and Biologicals Corporation Ltd | 15.42 | 0.72 | 0.00 | 306.06 | -39.50 | 0.00 |
| Astec Lifesciences Ltd | 552.30 | -3.93 | 0.00 | 157.94 | -363.14 | 0.00 |
Company Info
Ishita Drugs and Industries Ltd. was incorporated on the 5th February, 1992, and obtained the certificate for commencement of business on the 14th Feb. 1992, from the Registrar of Companies, Gujarat at Ahmedabad.. The main objects of the company are fully set out in the Memorandum and Articles of Association of the company and are also detailed herein the prospectus. 2005 -Ishita Drugs secures export order for API & 'PUMOJEL' 2012 -"Ishita Drugs & Industries Limited Declared "Best SME For Corporate Governance (Small)" At The Business Today-Yes Bank SME Awards 2011". 2013 - Ishita Drugs & Industries Ltd has appointed Mr. Niranjan Agrawal as a non-executive, independent director on the board of directors of the Company.
Ishita Drugs and Industries Ltd. was incorporated on the 5th February, 1992, and obtained the certificate for commencement of business on the 14th Feb. 1992, from the Registrar of Companies, Gujarat at Ahmedabad.. The main objects of the company are fully set out in the Memorandum and Articles of Association of the company and are also detailed herein the prospectus. 2005 -Ishita Drugs secures export order for API & 'PUMOJEL' 2012 -"Ishita Drugs & Industries Limited Declared "Best SME For Corporate Governance (Small)" At The Business Today-Yes Bank SME Awards 2011". 2013 - Ishita Drugs & Industries Ltd has appointed Mr. Niranjan Agrawal as a non-executive, independent director on the board of directors of the Company.
Read More
Parent Organisation
Ishita Drugs & Industries Ltd.
Founded
05/02/1992
Managing Director
Mr.Jagdish Agrawal
NSE Symbol
FAQ
The current price of Ishita Drugs and Industries Ltd is
The 52-week high for Ishita Drugs and Industries Ltd is
The market capitalization of Ishita Drugs and Industries Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Ishita Drugs and Industries Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Ishita Drugs and Industries Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Ishita Drugs and Industries Ltd shares.
The CEO of Ishita Drugs and Industries Ltd is Mr.Jagdish Agrawal, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
